300434 金石亚药
已收盘 02-06 15:00:00
资讯
新帖
简况
股市必读：金石亚药（300434）2月5日董秘有最新回复
证券之星 · 02-06 02:08
股市必读：金石亚药（300434）2月5日董秘有最新回复
金石亚药：公司在研项目相关情况详见公司定期报告
证券日报网 · 02-05 19:11
金石亚药：公司在研项目相关情况详见公司定期报告
金石亚药：股东减持节奏由其本人自主决策
证券之星 · 02-04
金石亚药：股东减持节奏由其本人自主决策
金石亚药：公司正积极推进真空镀膜技术的创新性研究
证券之星 · 02-04
金石亚药：公司正积极推进真空镀膜技术的创新性研究
股市必读：金石亚药（300434）1月29日董秘有最新回复
证券之星 · 01-30
股市必读：金石亚药（300434）1月29日董秘有最新回复
金石亚药（300434）披露2025年度业绩预告，1月28日股价下跌3.39%
证券之星 · 01-28
金石亚药（300434）披露2025年度业绩预告，1月28日股价下跌3.39%
【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司
金融投资报 · 01-28
【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司
金石亚药：公司真空镀膜设备暂未涉及太空光伏设备制造领域
证券之星 · 01-27
金石亚药：公司真空镀膜设备暂未涉及太空光伏设备制造领域
金石亚药：公司是国内感冒药一线产品“快克®”和“小快克®”的品牌缔造者和拥有者
证券之星 · 01-26
金石亚药：公司是国内感冒药一线产品“快克®”和“小快克®”的品牌缔造者和拥有者
金石亚药：1月22日高管郑志勇减持股份合计12万股
证券之星 · 01-23
金石亚药：1月22日高管郑志勇减持股份合计12万股
股市必读：金石亚药（300434）1月21日董秘有最新回复
证券之星 · 01-22
股市必读：金石亚药（300434）1月21日董秘有最新回复
股市必读：金石亚药（300434）1月16日董秘有最新回复
证券之星 · 01-19
股市必读：金石亚药（300434）1月16日董秘有最新回复
金石亚药最新公告：全资子公司迪耳药业取得高新技术企业证书和专精特新中小企业证书
证券之星 · 01-15
金石亚药最新公告：全资子公司迪耳药业取得高新技术企业证书和专精特新中小企业证书
股市必读：金石亚药（300434）1月13日董秘有最新回复
证券之星 · 01-14
股市必读：金石亚药（300434）1月13日董秘有最新回复
股市必读：金石亚药（300434）1月9日董秘有最新回复
证券之星 · 01-12
股市必读：金石亚药（300434）1月9日董秘有最新回复
每周股票复盘：金石亚药（300434）董事减持12.0万股 股价涨1.22%
证券之星 · 01-03
每周股票复盘：金石亚药（300434）董事减持12.0万股 股价涨1.22%
金石亚药：12月26日高管郑志勇减持股份合计12万股
证券之星 · 2025-12-29
金石亚药：12月26日高管郑志勇减持股份合计12万股
股市必读：金石亚药（300434）12月23日董秘有最新回复
证券之星 · 2025-12-24
股市必读：金石亚药（300434）12月23日董秘有最新回复
金石亚药：公司是“快克”品牌缔造者和拥有者
证券之星 · 2025-12-23
金石亚药：公司是“快克”品牌缔造者和拥有者
金石亚药：公司目前经营状况良好
证券之星 · 2025-12-18
金石亚药：公司目前经营状况良好
加载更多
公司概况
公司名称：
四川金石亚洲医药股份有限公司
所属行业：
医药制造业
上市日期：
2015-04-24
主营业务：
四川金石亚洲医药股份有限公司的主营业务是药品（包括化学药、中药饮片等）和保健食品（包括稀有人参皂苷产品和维生素矿物质补益类产品）的研发、生产与销售；增强塑料复合管道技术的研发和应用、真空镀膜设备的研发和制造。公司的主要产品是药品、保健食品、真空镀膜设备。
发行价格：
10.57
{"stockData":{"symbol":"300434","market":"SZ","secType":"STK","nameCN":"金石亚药","latestPrice":10.81,"timestamp":1770361437000,"preClose":10.72,"halted":0,"volume":9675220,"delay":0,"changeRate":0.0084,"floatShares":342000000,"shares":401999999,"eps":0.3246,"marketStatus":"已收盘","change":0.09,"latestTime":"02-06 15:00:00","open":10.8,"high":10.97,"low":10.78,"amount":105000000,"amplitude":0.0177,"askPrice":10.81,"askSize":303,"bidPrice":10.8,"bidSize":141,"shortable":0,"etf":0,"ttmEps":0.3246,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.72,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":11.79,"lowLimit":9.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401743872,"isCdr":false,"pbRate":1.71,"roa":"--","peRate":33.302526,"roe":"3.89%","epsLYR":0.23,"committee":0.159808,"marketValue":4343000000,"turnoverRate":0.0283,"status":0,"floatMarketCap":3698000000},"requestUrl":"/m/hq/s/300434","defaultTab":"news","newsList":[{"id":"2609583221","title":"股市必读：金石亚药（300434）2月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609583221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609583221?lang=zh_cn&edition=full","pubTime":"2026-02-06 02:08","pubTimestamp":1770314896,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，金石亚药报收于10.72元，下跌0.65%，换手率1.69%，成交量5.78万手，成交额6239.28万元。董秘最新回复投资者： 山有木兮木有枝，请问公司未来是否会积极在海南自贸港加强投资未来能够辐射全球？公司将会持续关注海南自贸港对医药产业发展的政策支持，为公司未来产业布局做好战略规划。交易信息汇总资金流向2月5日主力资金净流出383.23万元；游资资金净流出0.74万元；散户资金净流入383.97万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600001717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300434"],"gpt_icon":0},{"id":"2609372032","title":"金石亚药：公司在研项目相关情况详见公司定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2609372032","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609372032?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:11","pubTimestamp":1770289860,"startTime":"0","endTime":"0","summary":"证券日报网讯 2月5日，金石亚药在互动平台回答投资者提问时表示，公司在研项目相关情况详见公司定期报告。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-05/doc-inhkuptc5710047.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-05/doc-inhkuptc5710047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0028","300434","BK0077"],"gpt_icon":0},{"id":"2608361413","title":"金石亚药：股东减持节奏由其本人自主决策","url":"https://stock-news.laohu8.com/highlight/detail?id=2608361413","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608361413?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:53","pubTimestamp":1770209619,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：给你们减持的股东说一下，总共就一百万股能不能速度快点，磨磨唧唧减持了两个月了还有一多半没有减持！金石亚药回复：尊敬的投资者，您好！公司已根据相关法律法规的规定，履行了股东减持股份预披露公告的信息披露义务，股东减持节奏由其本人自主决策。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400039595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0028","BK0239"],"gpt_icon":0},{"id":"2608355552","title":"金石亚药：公司正积极推进真空镀膜技术的创新性研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2608355552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608355552?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:54","pubTimestamp":1770191657,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问：公司的真空镀膜是否能应用于光伏，半导体，新能源等领域？金石亚药回复：尊敬的投资者，您好！公司真空镀膜团队一直致力于研发和生产节能、环保及新能源等理念的真空镀膜设备，致力于帮助客户制定解决方案，成套工艺和设备交付的理念。公司正积极推进真空镀膜技术的创新性研究，探索该业务在光伏、半导体及其他新能源领域应用及推广。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400023303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0239","300434"],"gpt_icon":0},{"id":"2607053273","title":"股市必读：金石亚药（300434）1月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607053273","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607053273?lang=zh_cn&edition=full","pubTime":"2026-01-30 03:48","pubTimestamp":1769716093,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，金石亚药报收于10.84元，上涨0.18%，换手率3.1%，成交量10.59万手，成交额1.15亿元。公司《2025年度业绩预告》已于2026年1月29日在巨潮资讯网 进行披露。公司公告汇总2025年度业绩预告四川金石亚洲医药股份有限公司预计2025年度归属于上市公司股东的净利润为11,890.94万元至15,444.56万元，同比增长29.58%至68.31%；扣除非经常性损益后的净利润为9,790.10万元至13,343.72万元，同比增长18.96%至62.15%。非经常性损益对净利润的影响约为2,100.84万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000004126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2606171917","title":"金石亚药（300434）披露2025年度业绩预告，1月28日股价下跌3.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606171917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606171917?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:29","pubTimestamp":1769610555,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，金石亚药报收于10.82元，较前一交易日下跌3.39%，最新总市值为43.47亿元。该股当日开盘11.29元，最高11.29元，最低10.8元，成交额达1.7亿元，换手率为4.56%。近日，金石亚药发布2025年度业绩预告。公告显示，公司预计2025年度归属于上市公司股东的净利润为11,890.94万元至15,444.56万元，同比增长29.58%至68.31%；扣除非经常性损益后的净利润为9,790.10万元至13,343.72万元，同比增长18.96%至62.15%。非经常性损益对净利润的影响约为2,100.84万元。该数据为初步测算结果，未经审计。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800042861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2606921767","title":"【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2606921767","media":"金融投资报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606921767?lang=zh_cn&edition=full","pubTime":"2026-01-28 18:00","pubTimestamp":1769594400,"startTime":"0","endTime":"0","summary":"公司产品目前未涉及到6G网络业务中。未来若有达到法定信息披露标准的进展事项，公司将严格按照相关规定及时履行信息披露义务。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-28/doc-inhiwhqw3816161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0251","BK0215","300470","000935","BK0021","LU1997245094.SGD","BK0119","LU2148510915.USD","300434","03189","BK0235","BK0132","LU1580142542.USD","BK0077","BK0025","LU1997245177.USD","000568","BK0175","LU0052750758.USD","83189","BK0017","BK0028","BK0187","300471","LU0320764599.SGD","BK0012","BK0004","BK0188","LU0708995583.HKD","LU1064130708.USD","BK0156","BK0259","LU1655091616.SGD","LU1064131003.USD","BK0196","LU1781817850.SGD","BK0183","IE0005HP3H50.USD","LU0348805143.USD","BK1610"],"gpt_icon":0},{"id":"2606271936","title":"金石亚药：公司真空镀膜设备暂未涉及太空光伏设备制造领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2606271936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606271936?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:33","pubTimestamp":1769484822,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：真空镀膜技术是太空光伏关键核心制造工艺，公司的镀膜产品是否可以应用到太空光伏设备制造金石亚药回复：尊敬的投资者，您好！目前，公司真空镀膜设备暂未涉及太空光伏设备制造领域；未来，公司将持续深入拓展真空镀膜技术在其他领域的研发、合作可能性。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700016164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2606321869","title":"金石亚药：公司是国内感冒药一线产品“快克®”和“小快克®”的品牌缔造者和拥有者","url":"https://stock-news.laohu8.com/highlight/detail?id=2606321869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606321869?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:27","pubTimestamp":1769416028,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药01月26日在投资者关系平台上答复投资者关心的问题。奥司他韦和快克系列儿童药物增长率是多少？公司是国内感冒药一线产品“快克”和“小快克”的品牌缔造者和拥有者。多年来，打造了围绕感冒呼吸领域的品类多样的产品矩阵，除重点产品“快克”复方氨酚烷胺胶囊、“小快克”小儿氨酚黄那敏颗粒外，还有“快克清”磷酸奥司他韦胶囊、“快克露”愈美甲麻敏糖浆等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600017153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0239","BK0077","BK0028"],"gpt_icon":0},{"id":"2605947076","title":"金石亚药：1月22日高管郑志勇减持股份合计12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605947076","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605947076?lang=zh_cn&edition=full","pubTime":"2026-01-23 21:02","pubTimestamp":1769173339,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月23日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2026年1月22日公司董事郑志勇共减持公司股份12.0万股，占公司总股本为0.0299%。变动期间公司股价上涨1.1%，1月22日当日收盘报10.99元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300040549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300434","BK0077"],"gpt_icon":0},{"id":"2605248767","title":"股市必读：金石亚药（300434）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605248767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605248767?lang=zh_cn&edition=full","pubTime":"2026-01-22 02:56","pubTimestamp":1769021770,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，金石亚药报收于10.87元，下跌0.09%，换手率1.82%，成交量6.23万手，成交额6754.72万元。董秘最新回复投资者： 贵公司为什么不申请添加海南自贸概念？最重要子公司海南亚洲制药在海南，而且在海南有很重要的的土地投资。交易信息汇总资金流向1月21日主力资金净流出333.59万元；游资资金净流出50.96万元；散户资金净流入384.55万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200001148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2604297417","title":"股市必读：金石亚药（300434）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604297417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604297417?lang=zh_cn&edition=full","pubTime":"2026-01-19 03:27","pubTimestamp":1768764428,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，金石亚药报收于10.88元，下跌0.09%，换手率2.63%，成交量8.98万手，成交额9727.57万元。董秘最新回复投资者： 贵公司第四季度感冒药和流感药物销售额相比去年增长有多大？目前，公司财务部门正在积极推进2025年度财务数据核算工作。当日关注点来自交易信息汇总：1月16日主力资金净流入423.29万元，显示主力对金石亚药的积极介入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0239","300434"],"gpt_icon":0},{"id":"2603401601","title":"金石亚药最新公告：全资子公司迪耳药业取得高新技术企业证书和专精特新中小企业证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2603401601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603401601?lang=zh_cn&edition=full","pubTime":"2026-01-15 19:30","pubTimestamp":1768476658,"startTime":"0","endTime":"0","summary":"金石亚药(300434.SZ)公告称，公司全资二级子公司迪耳药业被认定为高新技术企业和专精特新中小企业，并分别收到相关证书。迪耳药业自获得高新技术企业认定后的连续三年内，将享受按15%的税率计缴企业所得税的优惠政策。上述证书的取得不会对公司当期经营业绩产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500035485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0239","399267","BK0028","BK0077"],"gpt_icon":0},{"id":"2603631496","title":"股市必读：金石亚药（300434）1月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603631496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603631496?lang=zh_cn&edition=full","pubTime":"2026-01-14 01:43","pubTimestamp":1768326189,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，金石亚药报收于11.24元，上涨3.4%，换手率8.99%，成交量30.75万手，成交额3.44亿元。董秘最新回复投资者： 强烈建议公司改名，要么体现医药行业重点去掉金石两字，要么体现综合性去掉亚药两字，现在的名字太不协调了董秘： 尊敬的投资者，您好！交易信息汇总资金流向1月13日主力资金净流入3138.59万元；游资资金净流入1618.85万元；散户资金净流出4757.44万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400000926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300434"],"gpt_icon":0},{"id":"2602577195","title":"股市必读：金石亚药（300434）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602577195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602577195?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:58","pubTimestamp":1768157890,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，金石亚药报收于10.78元，上涨0.94%，换手率3.33%，成交量11.4万手，成交额1.22亿元。董秘最新回复投资者： 金石亚药还要减持多久呢董秘： 尊敬的投资者，您好！公司董事、股东减持具体情况详见公司在巨潮资讯网上的《关于董事、股东减持股份的预披露公告》。交易信息汇总资金流向1月9日主力资金净流出432.36万元；游资资金净流入118.78万元；散户资金净流入313.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0028","BK0239"],"gpt_icon":0},{"id":"2600806721","title":"每周股票复盘：金石亚药（300434）董事减持12.0万股 股价涨1.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600806721","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600806721?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:03","pubTimestamp":1767380590,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，金石亚药报收于10.28元，较上周的10.79元下跌4.73%。本周，金石亚药12月29日盘中最高价报10.74元。12月31日盘中最低价报10.21元。金石亚药当前最新总市值41.3亿元，在化学制药板块市值排名113/150，在两市A股市值排名3847/5181。交易信息汇总：12月26日收盘价为10.79元，当日股价上涨1.22%。股本股东变化高管增减持2025年12月26日，公司董事郑志勇减持12.0万股，占公司总股本0.0299%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","300434","BK0239"],"gpt_icon":0},{"id":"2595478004","title":"金石亚药：12月26日高管郑志勇减持股份合计12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595478004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595478004?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:03","pubTimestamp":1767013380,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月29日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2025年12月26日公司董事郑志勇共减持公司股份12.0万股，占公司总股本为0.0299%。变动期间公司股价上涨1.22%，12月26日当日收盘报10.79元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900034996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300434"],"gpt_icon":0},{"id":"2593412353","title":"股市必读：金石亚药（300434）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412353?lang=zh_cn&edition=full","pubTime":"2025-12-24 01:37","pubTimestamp":1766511435,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，金石亚药报收于10.77元，下跌3.41%，换手率5.26%，成交量17.99万手，成交额1.95亿元。董秘最新回复投资者： 海南亚洲制药可以追溯1962年如今也将近64年历史，如此一个品牌居然不用。公司是国内感冒药一线产品“快克”和“小快克”的品牌缔造者和拥有者。公司长期深耕品牌建设，构建起“快克”“小快克”“今幸”等多元品牌矩阵。当日关注点来自交易信息汇总：12月23日主力资金净流出2405.65万元，显示主力资金持续撤离。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400000740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0239","BK0028"],"gpt_icon":0},{"id":"2593549315","title":"金石亚药：公司是“快克”品牌缔造者和拥有者","url":"https://stock-news.laohu8.com/highlight/detail?id=2593549315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593549315?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:54","pubTimestamp":1766480088,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药12月23日在投资者关系平台上答复投资者关心的问题。非要加上金石，可见公司对老品牌的不重视。公司是国内感冒药一线产品“快克”和“小快克”的品牌缔造者和拥有者。公司长期深耕品牌建设，构建起“快克”“小快克”“今幸”等多元品牌矩阵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300026232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0},{"id":"2592792611","title":"金石亚药：公司目前经营状况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2592792611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592792611?lang=zh_cn&edition=full","pubTime":"2025-12-18 11:36","pubTimestamp":1766028994,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药12月17日在投资者关系平台上答复投资者关心的问题。公司目前经营状况良好，股价走势受二级市场、行业环境、宏观经济环境等多重因素影响，请投资者注意投资风险。公司将密切关注股票市场动态和走势，加强市值管理工作，使公司价值得到合理体现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800012822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770538419358,"stockEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0295},{"period":"3month","weight":-0.0608},{"period":"6month","weight":0.0295},{"period":"1year","weight":0.2704},{"period":"ytd","weight":0.0516}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川金石亚洲医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23183人(较上一季度增加1.72%)","perCapita":"14757股","listingDate":"2015-04-24","address":"四川省成都市双流区九江镇万家社区","registeredCapital":"40174万元","survey":" 四川金石亚洲医药股份有限公司的主营业务是药品（包括化学药、中药饮片等）和保健食品（包括稀有人参皂苷产品和维生素矿物质补益类产品）的研发、生产与销售；增强塑料复合管道技术的研发和应用、真空镀膜设备的研发和制造。公司的主要产品是药品、保健食品、真空镀膜设备。","listedPrice":10.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金石亚药,300434,金石亚药股票,金石亚药股票老虎,金石亚药股票老虎国际,金石亚药行情,金石亚药股票行情,金石亚药股价,金石亚药股市,金石亚药股票价格,金石亚药股票交易,金石亚药股票购买,金石亚药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}